Starpharma Sp ADR (SPHRY)
$0.59
0.00 (0.00%)
SPHRY: Starpharma Is Leading the Field With Dendrimers
Starpharma's VivaGel is just starting to make its way into products across the globe, which means big things lie ahead for this Australian biotech stock.
Previous Close
$0.64
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
142
Day's Range
$0.59 - $0.59
52-Week Range
$0.52 - $0.94
Dividend & Yield
N/A (N/A)

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?